Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
30,767,343
-
Number of holders
-
38
-
Total 13F shares, excl. options
-
2,756,801
-
Shares change
-
-297,502
-
Total reported value, excl. options
-
$9,674,374
-
Value change
-
-$1,050,261
-
Number of buys
-
8
-
Number of sells
-
21
-
Price
-
$3.51
Institutional Holders of XBiotech Inc. - Common Shares, no par value (XBIT) as of Q4 2022
As of 31 Dec 2022 XBiotech Inc. - Common Shares, no par value (XBIT) had 46 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 2,756,801 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., CREDIT SUISSE AG/, GEODE CAPITAL MANAGEMENT, LLC, Oasis Management Co Ltd., BRIDGEWAY CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, MORGAN STANLEY, DIMENSIONAL FUND ADVISORS LP, and TWO SIGMA INVESTMENTS, LP.
This table shows 46 institutional shareholders of the security as of 31 Dec 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.